Cytokinetics, Incorporated
CYTKNASDAQHealthcare● Active
$67.90
$-3.58(-5.01%)
Market Cap$8.4B
P/E Ratio—
52W High$80.2
52W Low$31.99
Cytokinetics, Incorporated (CYTK) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CYTK · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $882.22M | $1076.01M | $614.82M | $782.58M | $471.64M |
| Net Receivables | $0.00M | $16.65M | $1.28M | $0.15M | $51.82M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $916.98M | $1107.94M | $628.05M | $795.19M | $535.67M |
| PP&E Net | $155.17M | $140.97M | $147.74M | $163.19M | $146.41M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $1424.54M | $1401.67M | $824.32M | $1014.77M | $841.32M |
| Liabilities | |||||
| Short-Term Debt | $41.18M | $11.52M | $10.08M | $0.96M | $0.00M |
| Accounts Payable | $105.61M | $20.37M | $21.51M | $25.61M | $21.09M |
| Total Current Liabilities | $202.45M | $179.67M | $102.68M | $84.62M | $71.86M |
| Long-Term Debt | $1115.98M | $645.60M | $607.37M | $609.62M | $142.84M |
| Total Liabilities | $2084.16M | $1537.05M | $1210.64M | $1122.67M | $597.46M |
| Stockholders Equity | |||||
| Retained Earnings | ($3486.72M) | ($2701.76M) | ($2112.24M) | ($1585.99M) | ($1207.62M) |
| Total Stockholders Equity | ($659.63M) | ($135.37M) | ($386.32M) | ($107.90M) | $243.86M |
| Total Liab & Equity(computed) | $1424.54M | $1401.67M | $824.32M | $1014.77M | $841.32M |
| Debt Summary | |||||
| Total Debt | $1284.24M | $788.68M | $755.77M | $750.30M | $269.93M |
| Net Debt | $402.02M | $693.82M | $642.75M | $684.72M | $157.26M |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Cytokinetics, Incorporated data
About Cytokinetics, Incorporated (CYTK) Balance Sheet
Cytokinetics, Incorporated (CYTK) balance sheet shows total assets of $1.42B with cash of $0.88B. Total liabilities are $2.08B, total debt $1.28B, and stockholders equity ($0.66B).
Frequently asked questions
CYTK · 4 questionsCytokinetics, Incorporated has total debt of $1.28B with net debt of $0.40B.
CYTK total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10